Viewing Study NCT06662669


Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2026-01-01 @ 10:18 PM
Study NCT ID: NCT06662669
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-10-29
First Post: 2024-10-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: YL-13027 and/or HY-0102 Combined With AG Regimen Chemotherapy for Metastatic Pancreatic Cancer
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module